MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0014767
Clinzerv Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.46 Cr
▲ 18% YoY
Net profit · FY 2025
₹10.81 Lakh
Net margin 3.1%
EBITDA · FY 2025
₹19.16 Lakh
EBITDA margin 5.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Clinzerv Pharmaceuticals Private Limited
Data last updated:
Clinzerv Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2019PTC352281. Its GSTIN is 07AAICC2637E1ZV (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohd Muntafa Rajput and Mohammad Mushahid Rajput.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed – 1 Dsidc Shed Okhla Industrial Area Ph – I New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.46 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹10.81 Lakh (net margin 3.1%) and EBITDA of ₹19.16 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
Clinzerv Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0014767). For more details, the company can be reached via its website clinzerv.com.
Company details
CIN U24239DL2019PTC352281
Registration Number 352281
Incorporation Date 05 July 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0014767
Recognitions & Rankings of Clinzerv Pharmaceuticals
Contact details
Clinzerv Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is clinzerv.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShed – 1 Dsidc Shed Okhla Industrial Area Ph – I New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Clinzerv Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Clinzerv Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Clinzerv Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Clinzerv Pharmaceuticals Private Limited, buy the company report.
Financials of Clinzerv Pharmaceuticals Private Limited
FY 2025 filings availableClinzerv Pharmaceuticals Private Limited reported revenue of ₹3.46 Cr (up 18% YoY) for FY 2025.
Revenue · FY 2025
₹3.46 Cr ▲ 18%
Net profit · FY 2025
₹10.81 Lakh margin 3.1%
EBITDA · FY 2025
₹19.16 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▲ 179%
3 years · compounded
▲ 382%
5 years · compounded
▲ 79%
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 18% growth in the latest year. EBITDA rose 179% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clinzerv Pharmaceuticals Private Limited, buy the company report.
Board of directors of Clinzerv Pharmaceuticals Private Limited
Clinzerv Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Muntafa Rajput | Director | 05 Jul 2019 | 7 Years 4 Months | Current |
| Mohammad Mushahid Rajput Also directs: Evolvia Healthcare Services Private Limited | Director | 05 Jul 2019 | 7 Years 4 Months | Current |
Auditor
Clinzerv Pharmaceuticals Private Limited is audited by YAV & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| YAV & CO | FY 2023 | 032910N |
Shareholding
The shareholding of Clinzerv Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Clinzerv Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Clinzerv Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clinzerv Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Clinzerv Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICC2637E1ZV | Delhi | Active | 03 Sep 2019 |
To see the full GST registrations and return filing status of Clinzerv Pharmaceuticals Private Limited, buy the company report.
Recent activity
Clinzerv Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Mohd Shoeb Alam ceased to be Director on 31 May 2022.
AGM
Clinzerv Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Clinzerv Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Mohd Shoeb Alam ceased to be Director.
Ceased
Shoyeb Mustafa Khan ceased to be Director.
Appointed
Mohammad Mushahid Rajput was appointed as Director.
Appointed
Mohd Muntafa Rajput was appointed as Director.
Incorporation
05 Jul 2019
Clinzerv Pharmaceuticals Private Limited was registered on 05 Jul 2019 with Roc Delhi I & aged 7 years 4 months as per MCA records.
Frequently asked questions
Clinzerv Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 July 2019 (7+ years old) and is registered under CIN U24239DL2019PTC352281.
Clinzerv Pharmaceuticals has 2 current directors:
- Mohd Muntafa Rajput - Director
- Mohammad Mushahid Rajput - Director
The latest financial statements of Clinzerv Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Clinzerv Pharmaceuticals is 07AAICC2637E1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Clinzerv Pharmaceuticals is U24239DL2019PTC352281. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clinzerv Pharmaceuticals was incorporated on 05 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Mohd Shoeb Alam ceased to be Director on 31 May 2022. Shoyeb Mustafa Khan ceased to be Director on 31 May 2022. Mohammad Mushahid Rajput was appointed as Director on 05 Jul 2019. Clinzerv Pharmaceuticals has 4 board changes on record in total.
Yes, Clinzerv Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0014767).
Clinzerv Pharmaceuticals can be reached through the website clinzerv.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Clinzerv Pharmaceuticals is at Shed – 1 Dsidc Shed Okhla Industrial Area Ph – I New Delhi, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages